Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.42457 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.41913 | 17 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.42121 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.36824 | 17 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.40098 | 19 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.46579 | 17 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.45483 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.40714 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.40901 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.41926 | 18 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.41045 | 17 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.41224 | 18 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.42055 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.41433 | 17 |